glycopyrrolate sialorrhea oral
Selected indexed studies
- Lithium-Induced Sialorrhea. (Cureus, 2023) [PMID:37265879]
- Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12-Week Controlled Trial. (Mov Disord, 2020) [PMID:32657457]
- Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions. (Paediatr Drugs, 2012) [PMID:22646067]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Glycopyrrolate for chronic drooling in children. (2012) pubmed
- Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12-Week Controlled Trial. (2020) pubmed
- Lithium-Induced Sialorrhea. (2023) pubmed
- Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions. (2012) pubmed
- Long-Term Stability of Glycopyrrolate Oral Solution Galenic Compound at Different Storage Conditions. (2024) pubmed
- In brief: Glycopyrrolate oral solution for sialorrhea. (2011) pubmed
- Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. (2010) pubmed
- Long-term efficacy of glycopyrrolate on sialorrhea in Goldenhar syndrome: a case report. (2022) pubmed
- Glycopyrrolate for Drooling in Children With Neurodisability: Multicenter Study. (2025) pubmed
- Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents. (2008) pubmed